Literature DB >> 2578576

Small and middle T antigens contribute to lytic and abortive polyomavirus infection.

H Türler, C Salomon.   

Abstract

Using three different polyomavirus hr-t mutants and two polyomavirus mlT mutants, we studied induction of S-phase by mutants and wild-type virus in quiescent mouse kidney cells, mouse 3T6 cells, and FR 3T3 cells. At different times after infection, we measured the proportion of T-antigen-positive cells, the incorporation of [3H]thymidine, the proportion of DNA-synthesizing cells, and the increase in total DNA, RNA, and protein content of the cultures. In permissive mouse cells, we also determined the amount of viral DNA and the proportion of viral capsid-producing cells. In polyomavirus hr-t mutant-infected cultures, onset of host DNA replication was delayed by several hours, and a smaller proportion of T-antigen-positive cells entered S-phase than in wild-type-infected cultures. Of the two polyomavirus mlT mutants studied, dl-23 behaved similarly to wild-type virus in many, but not all, parameters tested. The poorly replicating but well-transforming mutant dl-8 was able to induce S-phase, and (in permissive cells) progeny virus production, in only about one-third of the T-antigen-positive cells. From our experiments, we conclude that mutations affecting small and middle T-antigen cause a reduction in the proportion of cells responding to virus infection and a prolongation of the early phase, i.e., the period before cells enter S-phase. In hr-t mutant-infected mouse 3T6 cells, production of viral DNA was less than 10% of that in wild-type-infected cultures; low hr-t progeny production in 3T6 cells was therefore largely due to poor viral DNA replication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578576      PMCID: PMC254673     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Polyoma "tumor antigen": an activator of chromosome replication?

Authors:  R Weil; J Kára
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

3.  Host range mutants of polyoma virus.

Authors:  T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  The high affinity binding site on polyoma virus DNA for the viral large-T protein.

Authors:  P Gaudray; C Tyndall; R Kamen; F Cuzin
Journal:  Nucleic Acids Res       Date:  1981-11-11       Impact factor: 16.971

6.  Host range transforming gene of polyoma virus plays a role in virus assembly.

Authors:  R L Garcea; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Expression of the large T protein of polyoma virus promotes the establishment in culture of "normal" rodent fibroblast cell lines.

Authors:  M Rassoulzadegan; Z Naghashfar; A Cowie; A Carr; M Grisoni; R Kamen; F Cuzin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

9.  Characterization of polyoma virus T antigen.

Authors:  Y Ito; N Spurr; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  T-antigen expression by polyoma mutants with modified RNA splicing.

Authors:  S V Nilsson; G Magnusson
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  13 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Truncated forms of the polyomavirus middle T antigen can substitute for the small T antigen in lytic infection.

Authors:  D Templeton; S Simon; W Eckhart
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Phosphorylation of polyomavirus large T antigen: effects of viral mutations and cell growth state.

Authors:  B J Bockus; B Schaffhausen
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

4.  Regulation of c-myc and c-fos mRNA levels by polyomavirus: distinct roles for the capsid protein VP1 and the viral early proteins.

Authors:  J Zullo; C D Stiles; R L Garcea
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Expression of a mouse replacement histone H3.3 gene with a highly conserved 3' noncoding region during SV40- and polyoma-induced Go to S-phase transition.

Authors:  S Hraba-Renevey; M Kress
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

6.  Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector.

Authors:  D Davidson; J A Hassell
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Polyomavirus small T antigen enhances replication of viral genomes in 3T6 mouse fibroblasts.

Authors:  H Berger; E Wintersberger
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

8.  Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication.

Authors:  L Chen; M M Fluck
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Polyomavirus large and small T antigens cooperate in induction of the S phase in serum-starved 3T3 mouse fibroblasts.

Authors:  E Ogris; I Mudrak; E Wintersberger
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Enhancer-mediated role for polyomavirus middle T/small T in DNA replication.

Authors:  M C Chen; D Redenius; F Osati-Ashtiani; M M Fluck
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.